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in Finland since 1980 and also slightly from 1990, but real prices
have constantly decreased. Depending from the adjustment index
used, the real prices of all drugs have decreased 35–67% since
1980, or 16–40% since 1990. For reimbursed drugs the devel-
opment was similar; in Basic Refund category real prices have
decreased 24–46% since 1990, and even 45–72% since 1980.
Since the effectiveness of drugs has not decreased during the time
period studied, we suggest that the cost-effectiveness of drug
treatment has clearly increased in Finland.
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OBJECTIVES: To examine resource use and cost of Emergency
Department (ED) and hospital care for acute injuries resulting
from motorcycle accidents. METHODS: 2003 ED visit and hos-
pital discharge data from Massachusetts, where a mandatory all
age helmet law applies, were analyzed. Cases with motorcycle
accident-related injuries were identiﬁed by ICD-9 diagnosis and
external cause codes (E codes: E810.2–E825.2, E810.3–E825.3).
Inpatient cases were restricted to those admitted via ED. Type
and circumstance of injury, time of occurrence, demographics,
costs, length of stay (LOS)/visit, and disposition were examined.
Charges were adjusted by a 0.55 cost-to-charge ratio and
adjusted to national values. Cost estimates (2003US$) include
accommodations and ancillary services. RESULTS: Acute
injuries from motorcycle accidents resulted in 3066 ED visits and
420 hospitalizations during the year. Males comprised 87% of
cases; injured party was driver in 95%. Mean age was 32 years
(49% < 30 years). The majority (76%) occurred between May-
September, Friday-Sunday (52%), and 4:00 PM-midnight (54%).
Multiple injuries were noted in 44% of cases. Head injury/skull
fractures were coded for 8%. Fatalities were noted in <1% of
cases. On average, hospital LOS was 7 days (±10.1) with cost
per stay of $19,535 (±$34,688). At hospital discharge, 82%
went home (14% with home care), 17% transferred to sub-acute
facilities, 1% AMA. ED visit cost without hospitalization was
$787 (±$1,136) and was 2.7 hours (±3), on average. Manage-
ment of these injuries resulted in use of 2877 hospital days and
9274 ED visit hours at a cumulative cost of $10.5 million. CON-
CLUSIONS: This analysis shows that nearly half of the motor-
cycle accident victims sustained more than one injury; the
majority survived, and most acute injuries were managed suc-
cessfully in the ED. Although substantial, these acute care costs
are conservative estimates of injury-related costs, as they do not
include physician-related or post-acute care costs.
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OBJECTIVE: Internal Cost Allocation (ICA), (e.g. Haematol-
ogy—Transfusion medicine), becomes increasingly important,
which is mainly caused by the G-DRG system. To guarantee
optimal patient care, transparency on resources, costs and ben-
eﬁts is necessary. Therefore, in a ﬁrst step resource consumption
in platelet production was assessed to calculate ﬁnally costs from
the provider’s perspective. METHODS: Prospective cost-study
(full cost pricing/process cost ﬁnding). First, main processes of
platelet production were identiﬁed. Secondly, an Excel model for
standardized data entry and calculation was developed. Data
was collected by multimeasurement-time analysis (laboratory
processes three times, other processes ten times) and material
consumption by trained staff. For cost calculations, the deter-
mined average from previous analysis was consulted. Unit cost
data were collected from internal departments, e.g. materials
logistics or personnel management. RESULTS: Platelet produc-
tion consists of ﬁve processes: preparations before and after
donation, medical examination, donation itself and laboratory
tests to detect possible infections and increase blood safety. These
require one secretary, one operator (registered nurse), four
medical-technical-assistants and two doctors. The average of
62.44 minutes per doner could be prorated to the staff as
follows: secretary 8.55%, doctor 7.7%, medical-technical-
assistant 32.63%, and operator 51.12%. At the material con-
sumption, the biggest part belonged to the laboratory reagents,
which are needed for the standard-screening consisting of 
infection-serology, polymerase-chain-reaction, blood-type deter-
mination and the determination of the remaining leucocytes.
Cost evaluation is still ongoing. CONCLUSION: Platelet pro-
duction is a time- and resource-binding process. In the context
of ICA, transparency on costs is important for budget negotia-
tions, particularly when costs and beneﬁts of the introduction of
innovations in transfusion medicine shall be evaluated. It can be
assumed that the relevance of platelet transfusions due to new
therapy approaches is growing and in consequence, product dif-
ferentiation and economic aspects are getting more important for
resource allocation in German hospitals.
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OBJECTIVES: To evaluate user satisfaction from pharmaceuti-
cal care and determine the factors affecting it in Greece.
METHODS: A telephone survey was conducted by using a
random sample of 1000 individuals, stratiﬁed by age, county and
gender. A questionnaire was designed, containing questions
about the characteristics of the drug users, their out of pocket
spending on pharmaceuticals, the type and shape of the drug and
their satisfaction from medication. A logistic regression is done,
using as dependent variables various dimensions of satisfaction,
such as: (a) the drug effectiveness, (b) the drug shape, (c) the
health professionals’ responsiveness, (d) the appearances of side
effects and (e) the price adequacy. As independent variables
various characteristics of the respondents are used such as demo-
graphic, epidemiological and socioeconomic factors. RESULTS:
80% of Greek population is high satisﬁed from pharmaceutical
care, 91.93% from health professionals’ responsiveness, 86.03%
from the non appearances of side effects, 85.59 % from the drug
shape, 62.99 from price adequacy and 59.78% from the drug
effectiveness. Satisfaction from the drug shape, appearance of
side effects, drug effectiveness and improvement of health
depend on health status. Individuals of better health status have
a higher probability to evaluate higher their satisfaction from
medication. Satisfaction from health professionals’ responsive-
ness depends on age. Older individuals have a higher probabil-
ity to evaluate higher their satisfaction from health professionals’
responsiveness. Satisfaction from price adequacy depends on age,
social class and degree of urbanization. Lower social class older
individuals and cities residents have a lower probability to eval-
